Raymond James & Associates Praxis Precision Medicines, Inc. Transaction History

Raymond James & Associates

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 08, 2023	SELL	$1.88 - $2.49 $3,760 - $4,980	-2,000 Reduced 1.7%	115,540 $274,000
Q2 2022 Aug 12, 2022	SELL	$1.75 - $11.34 $1,389 - $9,003	-794 Reduced 0.67%	117,540 $288,000
Q1 2022 May 11, 2022	BUY	$10.21 - $20.29 $408 - $811	40 Added 0.03%	118,334 $1.21 Million
Q3 2021 Nov 02, 2021	BUY	$13.15 - $22.56 $25,918 - $44,465	1,971 Added 1.69%	118,294 $2.19 Million
Q2 2021 Aug 11, 2021	BUY	$18.28 - $33.05 $2.13 Million - $3.84 Million	116,323 New	116,323 $2.13 Million

75K

Ticker PRAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,576,100
Market Cap $1.84B
Description
Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. Its lead product candidates include PRAX-114, an extrasynaptic-preferring GABAA receptor positive allosteric modulator that is in Phase IIa clinical trial for the treatment of ...

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

Stay updated on Raymond James & Associates with notifications on news.